XThis page contains elements that are not optimised for mobile viewing. Click the link below to view the page in desktop mode.
Desktop mode
Mobile version

Decision by the Danish Medicines Agency – letters sent to companies

12 July 2010

On 11 June 2010, the Danish Medicines Agency made a decision on the future reimbursement status of medicinal products in ATC group A02 (products for acid-related disorders).

In the fact box to the right, you can find a link to the letter containing the decision which the Agency has sent to companies holding a marketing authorisation for medicinal products comprised by the decision.